Jean-Pierre Rosat

Managing Partner and Founder

19 past transactions

Positrigo

Venture Round in 2024
Positrigo AG is a Swiss company based in Zurich that specializes in the development, production, and sales of dedicated brain positron emission tomography (PET) scanners. Founded in 2018, Positrigo focuses on making functional brain imaging accessible for early detection of neurodegenerative diseases, particularly Alzheimer's disease. The company provides advanced scanning solutions that aid in diagnostics, treatment monitoring, and the development of new therapies for conditions such as Lewy body dementia, vascular dementia, and frontotemporal dementia. By enabling early diagnosis in an affordable manner, Positrigo aims to improve patient outcomes and support healthcare professionals in managing these complex medical conditions.

Neo Medical

Series B in 2024
Neo aims at transforming the current approach to spinal surgery by providing a unique answer to the worldwide strive for healthcare cost optimization through efficient, versatile and high quality systems.

Artiria Medical

Series A in 2024
Artiria Medical SA develops innovative micro-actuated devices aimed at treating vascular diseases, particularly in the brain. Founded in 2019 and based in Lausanne, Switzerland, the company focuses on enhancing the precision and control of surgical procedures involving catheters and guidewires. Its technology facilitates micromotion within brain arteries, thereby improving navigation during stroke treatments. By enabling surgeons to perform these complex procedures with greater accuracy, Artiria Medical contributes to better patient outcomes and the potential to save lives.

EcoRobotix

Series B in 2023
EcoRobotix Ltd is a Swiss company that specializes in the development and manufacture of autonomous farming machines designed for efficient weeding of row crops, meadows, and intercropping cultures. Founded in 2011 and based in Yverdon-les-Bains, the company offers an innovative product known as ARA, which employs advanced AI for plant recognition and ultra-high precision spraying. This technology allows the machine to detect weeds and apply a micro dose of herbicide directly to them, significantly reducing chemical usage by 70-95%. By utilizing a combination of camera systems, GPS RTK, and sensors, EcoRobotix enables farmers to minimize their environmental impact while lowering operational costs and enhancing crop yields.

Aspivix

Series A in 2022
Aspivix SA is a Swiss company specializing in the development of innovative medical devices aimed at enhancing gynecological procedures. Founded in 2015 and headquartered in Lausanne, Aspivix focuses on creating minimally invasive surgical instruments that prioritize patient comfort and safety. Its flagship product, CAREVIX, utilizes a patented suction technology to stabilize the cervix during procedures, effectively reducing pain and minimizing the risk of bleeding, lesions, and infections. This approach replaces traditional methods, such as the use of forceps, offering a gentler alternative for both women and gynecologists. Through its advancements, Aspivix aims to transform the landscape of gynecological care by making procedures safer and more efficient.

Positrigo

Series B in 2022
Positrigo AG is a Swiss company based in Zurich that specializes in the development, production, and sales of dedicated brain positron emission tomography (PET) scanners. Founded in 2018, Positrigo focuses on making functional brain imaging accessible for early detection of neurodegenerative diseases, particularly Alzheimer's disease. The company provides advanced scanning solutions that aid in diagnostics, treatment monitoring, and the development of new therapies for conditions such as Lewy body dementia, vascular dementia, and frontotemporal dementia. By enabling early diagnosis in an affordable manner, Positrigo aims to improve patient outcomes and support healthcare professionals in managing these complex medical conditions.

L2F

Venture Round in 2021
L2F Inc. is a robotic integrator based in Fremont, California, specializing in automated food manufacturing equipment for the restaurant industry. Founded in 2011, the company focuses on engineering solutions that enhance the efficiency of commercial kitchens and bars through robotics and artificial intelligence. L2F designs and manufactures various products, including the Skyflo, Servr, Frybot, and Pizzabot, which cater to the needs of food service operators. In addition to its equipment, L2F offers a range of services such as custom tooling, production line integration, data collection, and management, as well as consulting on engineering projects. By leveraging advancements in robotics, machine learning, and the Internet of Things, L2F aims to redefine food service processes and improve operational efficiency. As of October 2017, L2F operates as a subsidiary of The Middleby Corporation.

Giotto.ai

Venture Round in 2021
Giotto’s mission is to enable the collaboration between experts and AI. Thanks to our proprietary technology based on Topology, we develop a suite of SaaS applications designed to facilitate the interactive collaboration between users and machine learning models

EcoRobotix

Venture Round in 2021
EcoRobotix Ltd is a Swiss company that specializes in the development and manufacture of autonomous farming machines designed for efficient weeding of row crops, meadows, and intercropping cultures. Founded in 2011 and based in Yverdon-les-Bains, the company offers an innovative product known as ARA, which employs advanced AI for plant recognition and ultra-high precision spraying. This technology allows the machine to detect weeds and apply a micro dose of herbicide directly to them, significantly reducing chemical usage by 70-95%. By utilizing a combination of camera systems, GPS RTK, and sensors, EcoRobotix enables farmers to minimize their environmental impact while lowering operational costs and enhancing crop yields.

Scailyte

Seed Round in 2020
Scailyte has established a data-driven biomarker discovery platform that leverages unique expertise in single-cell data analysis and artificial intelligence. We are utilizing this platform to discover a new class of biomarkers, which are defined by the molecular profiles of disease-associated cells. This phenotypic approach to biomarker discovery is radically new and directly related to the biology of a disease, which maximizes the success rate for discovering sensitive and robust biomarkers.

Artiria Medical

Series A in 2020
Artiria Medical SA develops innovative micro-actuated devices aimed at treating vascular diseases, particularly in the brain. Founded in 2019 and based in Lausanne, Switzerland, the company focuses on enhancing the precision and control of surgical procedures involving catheters and guidewires. Its technology facilitates micromotion within brain arteries, thereby improving navigation during stroke treatments. By enabling surgeons to perform these complex procedures with greater accuracy, Artiria Medical contributes to better patient outcomes and the potential to save lives.

Positrigo

Series A in 2020
Positrigo AG is a Swiss company based in Zurich that specializes in the development, production, and sales of dedicated brain positron emission tomography (PET) scanners. Founded in 2018, Positrigo focuses on making functional brain imaging accessible for early detection of neurodegenerative diseases, particularly Alzheimer's disease. The company provides advanced scanning solutions that aid in diagnostics, treatment monitoring, and the development of new therapies for conditions such as Lewy body dementia, vascular dementia, and frontotemporal dementia. By enabling early diagnosis in an affordable manner, Positrigo aims to improve patient outcomes and support healthcare professionals in managing these complex medical conditions.

Scailyte

Series A in 2020
Scailyte has established a data-driven biomarker discovery platform that leverages unique expertise in single-cell data analysis and artificial intelligence. We are utilizing this platform to discover a new class of biomarkers, which are defined by the molecular profiles of disease-associated cells. This phenotypic approach to biomarker discovery is radically new and directly related to the biology of a disease, which maximizes the success rate for discovering sensitive and robust biomarkers.

Neo Medical

Series A in 2020
Neo aims at transforming the current approach to spinal surgery by providing a unique answer to the worldwide strive for healthcare cost optimization through efficient, versatile and high quality systems.

Giotto.ai

Venture Round in 2019
Giotto’s mission is to enable the collaboration between experts and AI. Thanks to our proprietary technology based on Topology, we develop a suite of SaaS applications designed to facilitate the interactive collaboration between users and machine learning models

Aspivix

Series A in 2018
Aspivix SA is a Swiss company specializing in the development of innovative medical devices aimed at enhancing gynecological procedures. Founded in 2015 and headquartered in Lausanne, Aspivix focuses on creating minimally invasive surgical instruments that prioritize patient comfort and safety. Its flagship product, CAREVIX, utilizes a patented suction technology to stabilize the cervix during procedures, effectively reducing pain and minimizing the risk of bleeding, lesions, and infections. This approach replaces traditional methods, such as the use of forceps, offering a gentler alternative for both women and gynecologists. Through its advancements, Aspivix aims to transform the landscape of gynecological care by making procedures safer and more efficient.

Aspivix

Seed Round in 2018
Aspivix SA is a Swiss company specializing in the development of innovative medical devices aimed at enhancing gynecological procedures. Founded in 2015 and headquartered in Lausanne, Aspivix focuses on creating minimally invasive surgical instruments that prioritize patient comfort and safety. Its flagship product, CAREVIX, utilizes a patented suction technology to stabilize the cervix during procedures, effectively reducing pain and minimizing the risk of bleeding, lesions, and infections. This approach replaces traditional methods, such as the use of forceps, offering a gentler alternative for both women and gynecologists. Through its advancements, Aspivix aims to transform the landscape of gynecological care by making procedures safer and more efficient.

EcoRobotix

Series A in 2018
EcoRobotix Ltd is a Swiss company that specializes in the development and manufacture of autonomous farming machines designed for efficient weeding of row crops, meadows, and intercropping cultures. Founded in 2011 and based in Yverdon-les-Bains, the company offers an innovative product known as ARA, which employs advanced AI for plant recognition and ultra-high precision spraying. This technology allows the machine to detect weeds and apply a micro dose of herbicide directly to them, significantly reducing chemical usage by 70-95%. By utilizing a combination of camera systems, GPS RTK, and sensors, EcoRobotix enables farmers to minimize their environmental impact while lowering operational costs and enhancing crop yields.

EcoRobotix

Seed Round in 2016
EcoRobotix Ltd is a Swiss company that specializes in the development and manufacture of autonomous farming machines designed for efficient weeding of row crops, meadows, and intercropping cultures. Founded in 2011 and based in Yverdon-les-Bains, the company offers an innovative product known as ARA, which employs advanced AI for plant recognition and ultra-high precision spraying. This technology allows the machine to detect weeds and apply a micro dose of herbicide directly to them, significantly reducing chemical usage by 70-95%. By utilizing a combination of camera systems, GPS RTK, and sensors, EcoRobotix enables farmers to minimize their environmental impact while lowering operational costs and enhancing crop yields.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.